137 related items for PubMed ID: 10100366
1. Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension.
Shohat J, Wittenberg C, Erman A, Rosenfeld J, Boner G.
Scand J Urol Nephrol; 1999 Feb; 33(1):57-62. PubMed ID: 10100366
[Abstract] [Full Text] [Related]
2. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[Abstract] [Full Text] [Related]
3. The effects of isradipine and spirapril as monotherapy and combined therapy on blood pressure, renal hemodynamics, natriuresis, and urinary kallikrein in hypertensive nephropathy.
Maccariello ER, Genelhu de Abreu Fagundes V, Francischetti EA.
Am J Hypertens; 1997 May; 10(5 Pt 1):541-5. PubMed ID: 9160765
[Abstract] [Full Text] [Related]
4. Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension.
Pittrow DB, Antlsperger A, Welzel D, Wambach G, Schardt W, Weidinger G.
Cardiovasc Drugs Ther; 1997 Nov; 11(5):619-27. PubMed ID: 9493699
[Abstract] [Full Text] [Related]
5. Concomitant administration of isradipine and spirapril prevents reduction of renal function induced by acute administration of spirapril in patients with reduced renal function.
Wittenberg C, Erman A, Shohat J, Boner G.
Blood Press Suppl; 1994 Nov; 1():48-9. PubMed ID: 8205299
[Abstract] [Full Text] [Related]
6. Short- and long-term effects of spirapril on renal hemodynamics in patients with essential hypertension.
Reams GP, Lau A, Knaus V, Bauer JH.
J Clin Pharmacol; 1993 Apr; 33(4):348-53. PubMed ID: 8473550
[Abstract] [Full Text] [Related]
7. Efficacy of slow-release oral isradipine in moderate-to-severe hypertension with add-on spirapril.
Abarquez RF, Sy RG, Castillo RR.
Am J Hypertens; 1993 Mar; 6(3 Pt 2):77S-79S. PubMed ID: 8466734
[Abstract] [Full Text] [Related]
8. Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy: effects on LVH regression and arrhythmogenic propensity.
Manolis AJ, Beldekos D, Handanis S, Haralabidis G, Hatzissavas J, Foussas S, Cokkinos DV, Bresnahan M, Gavras I, Gavras H.
Am J Hypertens; 1998 Jun; 11(6 Pt 1):640-8. PubMed ID: 9657622
[Abstract] [Full Text] [Related]
9. [Kidney function in hypertensive patients with chronic renal failure treated with the dual eliminated ACE-inhibitor spirapril].
Haufe CC, Sierakowski B, Jansa U, Stein G.
Med Klin (Munich); 1994 Aug 15; 89(8):416-20. PubMed ID: 7968874
[Abstract] [Full Text] [Related]
10. Spirapril in chronic renal failure.
Stein G, Sierakowski B, Jansa U, Haufe CC.
Blood Press Suppl; 1994 Aug 15; 2():54-60. PubMed ID: 8061847
[Abstract] [Full Text] [Related]
11. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
van den Meiracker AH, Man in 't Veld AJ, Admiraal PJ, Ritsema van Eck HJ, Boomsma F, Derkx FH, Schalekamp MA.
J Hypertens; 1992 Aug 15; 10(8):803-12. PubMed ID: 1325513
[Abstract] [Full Text] [Related]
12. A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension.
Nørgaard K, Jensen T, Christensen P, Feldt-Rasmussen B.
Blood Press; 1993 Dec 15; 2(4):301-8. PubMed ID: 8173700
[Abstract] [Full Text] [Related]
13. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
Hakamäki T, Lehtonen A.
Int J Clin Pharmacol Ther; 1997 Jun 15; 35(6):227-30. PubMed ID: 9208336
[Abstract] [Full Text] [Related]
14. ACE inhibition in chronic renal failure and in the treatment of diabetic nephropathy: focus on spirapril.
Jardine AG, Elliott HL.
J Cardiovasc Pharmacol; 1999 Aug 15; 34 Suppl 1():S31-4. PubMed ID: 10499562
[Abstract] [Full Text] [Related]
15. Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension.
Noble S, Sorkin EM.
Drugs; 1995 May 15; 49(5):750-66. PubMed ID: 7601014
[Abstract] [Full Text] [Related]
16. Antihypertensive and renal effects of isradipine in essential hypertension: focus on renin system activity.
Allikmets K, Parik T, Teesalu R.
Angiology; 1997 Nov 15; 48(11):977-83. PubMed ID: 9373050
[Abstract] [Full Text] [Related]
17.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
19. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
van den Broek SA, de Graeff PA, Smit AJ, Girbes AR, Journée, van Gilst WH, Hillege H, van Veldhuisen DJ, Wesseling H, Lie KI.
J Cardiovasc Pharmacol; 1995 Jan 15; 25(1):105-12. PubMed ID: 7723338
[Abstract] [Full Text] [Related]
20. Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension.
Hermida RC, Ayala DE, Fontao MJ, Mojón A, Alonso I, Fernández JR.
Chronobiol Int; 2010 May 15; 27(3):560-74. PubMed ID: 20524801
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
